In The Real World Study, Covaxin shows only 50% efficacy against symptomatic COVID-19:
In the real-world study done by Lancet Infectious Disease, BBV152 or Covaxin Indigenously produced vaccine showed only 50% efficacy against ...
In the real-world study done by Lancet Infectious Disease, BBV152 or Covaxin Indigenously produced vaccine showed only 50% efficacy against ...
Due to non-payment of Salaries for the past two months, Sanitation workers and nursing staff of All India Institute of ...
The Second Angle (TSA) Magazine covers a broad spectrum of topics including Entertainment, Lifestyle, education, Crypto, iGaming, Technology, fashion, beauty, relationships, celebrities, wellness, travel, and food. It also features user-generated content in the form of tips, guest post, forums, polls, contests and other interactive articles.
© 2017-23. The Second Angle. All Rights Reserved. Developed and Managed by SquareBase.io
© 2017-23. The Second Angle. All Rights Reserved. Developed and Managed by SquareBase.io